SA
PTCT icon

Sicart Associates’s PTC Therapeutics PTCT Stock Holding History

Sicart Associates’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,745
Closed -$209K – 77
2025
Q4 		$209K Buy
+2,745
New +$199K 0.06% 73
2023
Q3 		– Sell
-5,100
Closed -$207K – 68
2023
Q2 		$207K Sell
5,100
-3,075
-38% -$150K 0.08% 63
2023
Q1 		$396K Hold
8,175
– – 0.15% 53
2022
Q4 		$312K Hold
8,175
– – 0.11% 63
2022
Q3 		$410K Hold
8,175
– – 0.15% 56
2022
Q2 		$327K Hold
8,175
– – 0.1% 60
2022
Q1 		$305K Hold
8,175
– – 0.08% 72
2021
Q4 		$328K Hold
8,175
– – 0.09% 78
2021
Q3 		$304K Hold
8,175
– – 0.08% 86
2021
Q2 		$346K Hold
8,175
– – 0.08% 86
2021
Q1 		$387K Sell
8,175
-25
-0.3% -$1.49K 0.1% 76
2020
Q4 		$500K Hold
8,200
– – 0.12% 73
2020
Q3 		$383K Hold
8,200
– – 0.11% 76
2020
Q2 		$416K Hold
8,200
– – 0.13% 72
2020
Q1 		$366K Sell
8,200
-525
-6% -$26.4K 0.14% 67
2019
Q4 		$419K Hold
8,725
– – 0.14% 75
2019
Q3 		$295K Buy
8,725
+550
+7% +$23.9K 0.1% 87
2019
Q2 		$368K Hold
8,175
– – 0.15% 67
2019
Q1 		$308K Hold
8,175
– – 0.13% 70
2018
Q4 		$281K Hold
8,175
– – 0.14% 72
2018
Q3 		$384K Hold
8,175
– – 0.18% 66
2018
Q2 		$276K Hold
8,175
– – 0.14% 77
2018
Q1 		$221K Buy
+8,175
New +$207K 0.13% 84
2017
Q1 		– Sell
-431,135
Closed -$4.7M – 100
2016
Q4 		$4.7M Buy
+431,135
New +$4.52M 3.25% 5

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sicart Associates's PTCT Position: Q1 2026 in Review

Sicart Associates sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 2,745 shares — an estimated $209K sold.

Sicart Associates first reported a position in PTCT in Q4 2016 and held it in 24 quarters. The position peaked at $4.7M in Q4 2016. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Sicart Associates reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Sicart Associates sold 2,745 PTC Therapeutics shares in Q1 2026, an estimated $209K.
  • Sicart Associates first reported a position in PTC Therapeutics in Q4 2016 and held it in 24 quarters.
  • Sicart Associates's PTC Therapeutics position peaked at $4.7M in Q4 2016.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Sicart Associates's 13F filing for Q1 2026, filed 21 Apr 2026.